- Report
- August 2025
- 199 Pages
Global
From €3156EUR$3,545USD£2,728GBP
€3507EUR$3,939USD£3,031GBP
- Report
- May 2025
- 150 Pages
Global
From €5297EUR$5,950USD£4,578GBP
- Report
- August 2025
- 354 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- June 2025
- 185 Pages
Global
From €4006EUR$4,500USD£3,462GBP
- Report
- June 2025
- 81 Pages
Global
From €3500EUR$4,211USD£3,131GBP
- Report
- August 2025
- 199 Pages
Global
From €3156EUR$3,545USD£2,728GBP
€3507EUR$3,939USD£3,031GBP
- Report
- August 2025
- 181 Pages
Global
From €3156EUR$3,545USD£2,728GBP
€3507EUR$3,939USD£3,031GBP
- Report
- August 2025
- 194 Pages
Global
From €3156EUR$3,545USD£2,728GBP
€3507EUR$3,939USD£3,031GBP
- Report
- August 2025
- 187 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1113EUR$1,250USD£962GBP
- Report
- June 2025
- 150 Pages
Global
From €2403EUR$2,699USD£2,077GBP
- Report
- February 2024
- 126 Pages
Global
From €2130EUR$2,392USD£1,840GBP
€2662EUR$2,990USD£2,301GBP
- Report
- May 2024
- 129 Pages
Global
From €5786EUR$6,499USD£5,001GBP
- Report
- April 2023
- 110 Pages
Global
From €4229EUR$4,750USD£3,655GBP
- Report
- March 2021
- 130 Pages
Global
From €13350EUR$14,995USD£11,538GBP

The Intravenous Iron market is a segment of the Hematological Drugs market, which includes drugs used to treat anemia and other blood disorders. Intravenous Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. Intravenous Iron is administered directly into the bloodstream, allowing for a more rapid increase in iron levels than oral iron supplements.
Intravenous Iron is used in a variety of settings, including hospitals, clinics, and home care. It is often prescribed to patients who are unable to take oral iron supplements due to gastrointestinal issues or who require a more rapid increase in iron levels.
The Intravenous Iron market is highly competitive, with a number of companies offering products in this space. Some of the major players in the market include Vifor Pharma, Fresenius Kabi, American Regent, and B. Braun. Show Less Read more